| 中文名 | 地夫可特 |
|---|---|
| 英文名 | 21-Deacetoxy Deflazacort |
| 中文别名 |
地夫可特中间体(D8)
D5,地那查可特 21-脱乙酰氧基地夫可特 (11B,16B)-11-羟基-2'-甲基-5'H-孕甾-1,4-二烯并[17,16d]异恶唑-3,20-二酮 脱乙酰氧基地夫可特 中间体(D5) 21-去乙酰地夫可特 地夫可特脱乙酰氧 地夫可特杂质20 地夫可特|地那查可特|13-2 |
| 英文别名 |
Deflazacort Intermediate (D5)
21-Desacetoxydeflazacort (11β,16β)-11-hydroxy-2'-Methyl-5'H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (6,6bS,7S,8aS,8bS,11,12aS,12bS) 5′βH-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione,11β-hydroxy-2′-methyl (6,6bS,7S,8aS,8bS,11,12aS,12bS)-8b-Acetyl-7-hydroxy-6a,8a,10-trimethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d]oxazol-4(2H)-one deflazacort 11β-hydroxy-2'-methyl-5'βh-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione Desacetoxy Deflazacort βH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione Deflazacort Intermediates(D5) Deflazacort intermediates (4,4BS,5S,6AS,9,10AS,10BS)-6B-ACETYL-5-HYDROXY-4A,6A,8-TRIMETHYL-4A,4B,5,6,6A,6B,9A,10,10A,10B,11,12-DODECAHYDRO-9-OXA-7-AZA-PENTALENO[2,1-A]PHENANTHREN-2-ONE Deflazacort Desacetoxy (11b,16b)-11-hydroxy-2'-Methyl-5'-H-pregna-1,4-dieno 17,16 oxazole-3,20-dione DEFLAZACORT INTERMEDIATE 8b-Acetyl-7-hydroxy-6a,8a,10-trimethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d]oxazol-4(2H) (11β,16β)-11β-hydroxy-2'-Methyl-5βH-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 11β-hydroxy-2'-methyl-(16β)-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-DeacetoxyDeflazacor (11B,16B)-11-HYDROXY-2-METHYL -5H-PREGNA-1,4-DIENO (17,16D)OXAZOLE-3,20-DIONE[D5] Deflazacort Desacetoxy Impurity Deflazacort Impurity 20 11beta-Hydroxy-2'-methyl-5'betaH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione PREGNA-1,4-DIENE-11B-OL-17A,16A-D-2-METHYL-OXAZOLINE-3,20-DIONE 11b-hydroxy-2-methyl-5b-H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 11BETA-HYDROXY-2'-METHYL-PREGNA-1,4-DIENE[17,16-D]OXAZOLE -__PROTECTED__3,20-DIONE Intermediate of Difu Ke Te Deflazacort Impurity 3 (11B,16b)-11-hydroxy-2’-methyl-5’-h-pregna-1,4-dieno[17,16]oxazole-3,20-dione (11B, 16B)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO[17,16-D]OXAZOLE-3,20-DIONE 5'H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 11-hydroxy-2'-methyl-, (11β,16β) 1,4-Pregnadiene-11beta-ol-3,20-dione-[17alpha,16alpha-d]-2'-met (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Acetyl-5-hydroxy-4a,6a,8-trimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-2-one |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 544.2±50.0 °C at 760 mmHg |
| 熔点 | >250°C (dec.) |
| 分子式 | C23H29NO4 |
| 分子量 | 383.481 |
| 闪点 | 282.9±30.1 °C |
| 精确质量 | 383.209656 |
| PSA | 75.96000 |
| LogP | 1.06 |
| 蒸汽压 | 0.0±3.3 mmHg at 25°C |
| 折射率 | 1.675 |
| 储存条件 | Refrigerator |
| 海关编码 | 2937290090 |
|---|
|
~%
13649-88-2 |
| 文献:Steroids, , vol. 13, p. 383 - 397 |
|
~%
13649-88-2 |
| 文献:Journal of medicinal chemistry, , vol. 10, # 5 p. 799 - 802 |
|
~%
13649-88-2 |
| 文献:Journal of medicinal chemistry, , vol. 10, # 5 p. 799 - 802 |
|
~%
13649-88-2 |
| 文献:Steroids, , vol. 13, p. 383 - 397 |
|
~%
13649-88-2 |
| 文献:Steroids, , vol. 13, p. 383 - 397 |
|
~%
13649-88-2 |
| 文献:Steroids, , vol. 13, p. 383 - 397 |
|
~%
13649-88-2 |
| 文献:Journal of medicinal chemistry, , vol. 10, # 5 p. 799 - 802 |
|
~%
13649-88-2 |
| 文献:Steroids, , vol. 13, p. 383 - 397 |
|
~%
13649-88-2 |
| 文献:Steroids, , vol. 13, p. 383 - 397 |
| 上游产品 2 | |
|---|---|
| 下游产品 1 | |
| 海关编码 | 2937290090 |
|---|